Week 564 Review - SIPP has a good week but Probiotix and Jubilee Metals take off the shine.

A pretty good week spoiled by drops in JLP:Jubilee Metals and PBX:Probiotix Health. The deficit between cost and value improved by £1,229 to £150,316 and the deficit between injection and value reduced to £58,465. Total portfolio value increased to £126,674.

Worst performer was DXRX:Diaceutics, dropping 14% after what looked like pretty good results. If I had any cash in my ISA I'd be buying more.

PBX:Probiotix Health announced a new strategic alliance which is going to be very positive, and the share price promptly fell 10%. I don't understand what's going on.

PRU:Prudential dropped 5% for no obvious reason. They had their AGM this week but there didn't seem to be anything controversial

SBRE:Sabre Insurance also fell 5% and dropped into the red by 1%.

That was the end of the bad news.

FSG:Foresight Group Holdings, IES:Invinity Energy and INVP:Investec all went up 5%.

EDV:Endeavour Mining, PAGE:Pagegroup, POLR:Polar Capital and TRU:Trufin went up 6%, the latter after announcing a tender offer at a premium to the current share price.

SCT:Softcat went up 7%, and after last week's rally my holding is up by 8%.

GGP:Greatland Resources and OPTI:Optibiotix both went up 9%, the latter after decent final results, but 0.5p is a drop in the ocean to what I need.

ATYM:Atalya Mining had a great week, climbing 11% and taking my holding 2% into profit.

Share of the Week is W7L:Warpaint London, which went up 14% but my holding is still 10% down. This is probably my most volatile share now FXPO:Ferrexpo is suspended.

Here's the ISA and shares portfolio after week 44 of year 11.

			Weekly Change
Cash	£113.54		+£0
Portfolio cost	£116,490.29		+£0
Portfolio sell value (bid price-commission)	£32,505.64	(-72.1%)	-£314.36
Potential profits	£499.96		+£66.48
Yr 11 Dividends	£86.83		+£0
Yr 11 Interest	£1.57		+£0
Yr 11 Profit from sales	£873.14		+£0
Yr 11 proj avg monthly profit	£87.00	(1.2%)	-£2.02
Total Dividends	£12,574.90		+£0
Total Interest	£10.14		+£0
Total Profit from sales	£18,433.41		+£0
Average monthly cash profit	£233.37	(3.2%)	-£0.41
(Sold stocks profit + Dividends - Fees / Months)

The drops was due to the large JLP:Jubilee Metals and PBX:Probiotix Health holdings dropping more than OPTI:Optibiotix went up, as well as the big drop in DXRX:Diaceutics. Potential profits increased due to another positive week for IES:Invinity Energy, and TRU:Trufin climbing 6%.

It's been pretty flat for a while now

Hugging the trend line!

The SIPP looks like this after week 548 overall and week 28 of year 11.

			Weekly Change
Cash	£846.08		+£130.82
Portfolio cost	£159,540.59		+£0
Portfolio sell value (bid price - commission)	£93,208.84	(-41.6%)	+£1,543.99
Potential profits	£13,514.80		+£1,159.78
Yr 11 Dividends	£1.209.80		+£130.82
Yr 11 Interest	£12.26		+£0
Yr 11 Profit from sales	£9,216.80		+£0
Yr 11 proj avg monthly profit	£1,597.77	(19.4%)	-£38.18
Total Dividends	£19,430.00		+£130.82
Total Interest	£32.96		+£0
Total Profit from sales	£33,883.31		+£0
Average monthly cash profit	£408.11	(5.0%)	+£0.29

Cash went up £130 thanks to a £29 dividend from ARBB:Arbuthnot Banking, £20 from BPCR:BioPharma Credit, £9 from ESTC:European Smaller Companies Trust, £24 from FRES:Fresnillo, £19 from GAW:Games Workshop and £26 from UKW:Greencoat UK Wind.

Portfolio value increased by £1,543, most of which was increased profits, and the dividends were enough to slightly improve long term performance.

Still trying to get back to the injection line.

Back on the trend line is progress.

Another 4 dividends coming next week, so performance is at least staying constant without me needing to sell any shares. Only just over 2 months before I re-generate my magic formula ranking, which could see some nice profits realised, although I think I'd rather my holdings remain in the top 50 so I can get more.